Compare Edwards Lifesciences Corporation Common Stock (EW) vs Zscaler Inc (ZS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Zscaler Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Zscaler Inc trades at $218.51 (market cap $34.82B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Edwards Lifesciences Corporation Common Stock is more actively traded (6,520,488 versus 2,678,909). Which is the better fit depends on your goals.
| EW | ZS | |
|---|---|---|
Market Cap | $48.56B | $34.82B |
Volume | 6,520,488 | 2,678,909 |
Sector | Health | Technology |
52-Week High | $95.18 | $336.27 |
52-Week Low | $72.65 | $118.05 |
Enterprise Value | $45.01B | $33.20B |
Typical Hold Time | — | 41 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zscaler (ZS) trades at $213.55, up 0.61% with a bullish technical outlook supported by moving averages. The company shows strong revenue growth from $1.1B in 2022 to $2.67B in 2025, though it remains unprofitable with a net margin of -1.88%. Recent earnings beats and a 79.6% analyst buy rating highlight positive momentum, while a legal investigation and executive departure present near-term risks.
The stock offers growth potential with a consensus price target of $222.83 (4.3% upside), driven by AI security demand and expanding platform adoption. Key risks include profitability challenges, competitive pressures, and market volatility. Investor Day on October 6 may provide catalysts, but caution is warranted given high valuation multiples and negative cash flow projections for 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Zscaler Inc
Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →
